Cincera
Focused on the discovery and development of new drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity/metabolic diseases, with potential applications in many other disease areas including cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD28—42m (Dealroom.co estimates Feb 2018.)
Melbourne Victoria (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
AUD7.0m | Seed | ||
| N/A | AUD1.0m | Grant | |
* | $500k | Early VC | |
| Total Funding | AUD8.8m | ||
Related Content
Recent News about Cincera
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.